echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Immunology News > ARD: Survival rates of French hospitalized patients with systemic lupus erythematosus after COVID-19-related organ failure: a national study

    ARD: Survival rates of French hospitalized patients with systemic lupus erythematosus after COVID-19-related organ failure: a national study

    • Last Update: 2021-12-27
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Objective: Many SLE patients with immune suppression drugs, making it easier to infect virus and often suffer from chronic kidney or heart vascular disease, which is a serious COVID-19 additional risk factors
    .


    On the other hand, glucocorticoids and hydroxychloroquine are the most widely used drugs for the treatment of SLE and have also been studied for the treatment of COVID-19


    Objective: Many SLE patients with immune suppression drugs, making it easier to infect virus and often suffer from chronic kidney or heart vascular disease, which is a serious immune infected vascular COVID-19 COVID-19 additional risk factors


    Methods: The researchers used the French national medical / administrative hospital database in 2011 Nian 1 month to 2020 Nian 11 were cohort study during the month
    .


    In 2020 Nian 11 prior months in French hospital diagnosis is COVID-19-AOF of each SLE patients and five with COVID-19-AOF Africa SLE random match the patient


    Methods: The researchers used the French national medical / administrative hospital database in 2011 Nian 1 month to 2020 Nian 11 were cohort study during the month


    Results: 2020 Nian 3 months to 11 months, France has 127,380 hospitalizations in line with COVID-19-AOF defined above, wherein 196 times consistent with a diagnosis of SLE patients


    Conclusion: COVID-19-AOF is related to the delayed prognosis of SLE patients


    Source:

    Source:

    Mageau A, Papo T, Ruckly S , et al .


    Survival after COVID-19-associated organ failure among inpatients with systemic lupus erythematosus in France: a nationwide study.
    Annals of the Rheumatic DiseasesPublished Online First: 10 December 2021.


    Mageau A, Papo T, Ruckly S , et al .
    Survival after COVID-19-associated organ failure among inpatients with systemic lupus erythematosus in France: a nationwide study.
    Annals of the Rheumatic DiseasesPublished Online First: 10 December 2021.
    doi: 10.
    1136 /annrheumdis-2021-221599 , et al Annals of the Rheumatic Diseases  leave a message here
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.